Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00323
|
|||||
Drug Name |
Budesonide
|
|||||
Synonyms |
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde; (RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde; (S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione; 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione; 16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione; 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione; 16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; 16alpha-,17alpha-butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione; B 7777; Bidien; Budecort Inhaler; Budenofalk; Budeson; Budesonide (JAN/USAN/INN);Budesonide [USAN:INN:BAN:JAN]; Budesonide Easyhaler; Budesonide MMX; Budesonido; Budesonido [INN-Spanish]; Budesonidum; Budesonidum [INN-Latin]; Budiair; Cortivent; Dexbudesonide; Dexbudesonide [INN]; Entocort; Entocort (TN); Entocort EC; Entocort EC (TN); GionaEasyhaler; Horacort; Inflammide; MAP-0010; Micronyl; Miflonide; Noex (TN); Preferid; Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-,and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; Pulmaxan; Pulmaxan turbohaler; Pulmicort; Pulmicort (TN); Pulmicort Flexhaler; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Topinasal; Pulmicort turbuhaler; Respules; Rhinocort; Rhinocort (TN); Rhinocort Aqua; Rhinocort Turbuhaler; Rhinocort alpha; Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide; S 1320; S-1320; Spirocort; UDB; Unit dosebudesonide
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antiinflammatory Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C25H34O6
|
|||||
Canonical SMILES |
CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
|
|||||
InChI |
InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
|
|||||
InChIKey |
VOVIALXJUBGFJZ-KWVAZRHASA-N
|
|||||
CAS Number |
CAS 51333-22-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 430.5 | Topological Polar Surface Area | 93.1 | ||
Heavy Atom Count | 31 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
2.5
|
|||||
PubChem CID | ||||||
PubChem SID |
10321783
, 103455384
, 103914268
, 104170124
, 11466546
, 11467666
, 11486132
, 11528595
, 12013315
, 121360873
, 121362487
, 121363112
, 124749512
, 124800069
, 124886759
, 126627527
, 126651544
, 127278596
, 127278597
, 14807548
, 14929955
, 17404737
, 24278277
, 39289945
, 46504869
, 47646553
, 47720602
, 47869643
, 47943751
, 48169361
, 49698535
, 50105232
, 53777280
, 53789711
, 56394980
, 56422168
, 57357962
, 77787022
, 7847312
, 7978823
, 81092787
, 855541
, 85787937
, 8616471
, 90341081
, 90473637
, 92125441
, 92303636
, 92721807
, 93576669
|
|||||
ChEBI ID |
ChEBI:3207
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.